In fact, in our cohort we observed that most of conditions associated with higher overall mortality in multivariate analysis (i.e. older age, hypertension, uncontrolled hematological disease and high levels of CRP) were overrepresented in the non-SCT cohort, which may explain in part the lower mortality observed in SCT recipients. This evidence concerns the gene CRP and hematologic disorder.